Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

16.12

+0.12 (0.75%)

At close: Aug 14, 2026, 4:00 PM EDT

15.80

-0.32 (-1.99%)

After-hours: Aug 14, 2026, 7:56 PM EDT

Janux Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	986	830	3,087	495	547	821
Market Cap Growth	-34.30%	-73.11%	523.34%	-9.51%	-33.35%	-
Enterprise Value	36	-136	2,452	170	233	434
Last Close Price	16.12	13.80	53.54	10.73	13.17	19.73
PS Ratio	41.06	83.00	291.54	61.27	63.54	225.73
PB Ratio	1.06	0.87	3.02	1.44	1.71	2.24
P/TBV Ratio	1.06	0.87	3.02	1.44	1.71	2.24
EV/Sales Ratio	1.48	-	231.60	21.08	27.00	119.25
Debt / Equity Ratio	0.02	0.02	0.02	0.07	0.08	0.00
Net Debt / Equity Ratio	-1.02	-0.99	-0.98	-0.93	-0.94	-1.02
Net Debt / EBITDA Ratio	6.71	6.07	10.35	4.50	4.55	11.42
Net Debt / FCF Ratio	22.66	11.34	22.69	6.09	6.11	20.30
Asset Turnover	0.02	0.01	0.02	0.02	0.02	0.02
Quick Ratio	16.25	38.92	59.03	26.56	19.85	29.32
Current Ratio	16.35	39.04	59.21	26.80	20.14	29.46
Return on Equity (ROE)	-10.70%	-11.48%	-10.09%	-17.53%	-18.36%	-17.50%
Return on Assets (ROA)	-8.80%	-9.55%	-8.57%	-12.25%	-11.27%	-10.39%
Return on Capital Employed (ROCE)	-15.20%	-16.10%	-9.50%	-19.90%	-19.30%	-9.00%
Earnings Yield	-10.41%	-13.69%	-2.23%	-11.77%	-11.52%	-3.98%
FCF Yield	-4.25%	-10.03%	-1.43%	-10.59%	-9.02%	-2.25%
Buyback Yield / Dilution	-6.20%	-15.28%	-22.12%	-6.14%	-76.24%	-2471.20%

SEC Filings: 10-K · 10-Q